CORT vs PEG · P/E 199, rev $675.0M vs P/E 18, rev $10.29B
Corcept Therapeutics Incorporated (CORT) versus Public Service Enterprise Group Inc (PEG) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Latest reported CORT revenue for 2024-12-31 was $675.0M. Net income was $141.2M. Revenue was up 39.9% from 2023-12-31 to 2024-12-31. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Not investment advice. Open the CORT and PEG stock pages for the full models.
Not investment advice.